Farhan Khalid
-
- Multiple Myeloma Research and Treatments 5
- Hematopoietic Stem Cell Transplantation 3
- Iron Metabolism and Disorders 3
-
- Hemoglobinopathies and Related Disorders 5
-
- CAR-T cell therapy research 5
- Cancer Diagnosis and Treatment 3
-
- Prostate Cancer Treatment and Research 3
-
- Protein Degradation and Inhibitors 3
- Co-authors
- Muhammad Ashar AliFaiz AnwerSana Irfan KhanAli JaanKenneth ChenHong Hong HuangYu Guang TanKae Jack Tay
- Cited by
- HematologyGeneticsOncology
- Journals
- Blood (10 papers)British Journal of Oral and Maxillofacial Surgery (3 papers)The Prostate (2 papers)
- Partner nations
- United StatesPakistanIndia
In The Last Decade
Farhan Khalid
44 papers receiving 256 citations
Peers
Comparison fields: 5 of 69
- Hematology 39
- Genetics 28
- Oncology 66
- Hepatology 18
- Pulmonary and Respiratory Medicine 54
Countries citing papers authored by Farhan Khalid
This map shows the geographic impact of Farhan Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhan Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhan Khalid more than expected).
Fields of papers citing papers by Farhan Khalid
This network shows the impact of papers produced by Farhan Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhan Khalid. The network helps show where Farhan Khalid may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Farhan Khalid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 37 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 18 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 3 | |
| 15 | 2020 | 12 | |
| 16 | 2020 | 9 | |
| 17 | 2020 | 2 | |
| 18 | 2020 | 25 | |
| 19 | 2013 | 2 | |
| 20 | 1997 | 0 |
About Farhan Khalid
Farhan Khalid is a scholar working on Hematology, Genetics, Internal Medicine, Oncology and Family Practice, having authored 55 papers that have together received 265 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), CAR-T cell therapy research (5 papers), Hemoglobinopathies and Related Disorders (5 papers), Hematopoietic Stem Cell Transplantation (3 papers), Iron Metabolism and Disorders (3 papers), Cancer Diagnosis and Treatment (3 papers), Protein Degradation and Inhibitors (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Hematology (39 citations), Genetics (28 citations), Oncology (66 citations), Hepatology (18 citations) and Pulmonary and Respiratory Medicine (54 citations). Farhan Khalid has collaborated with scholars based in United States, Pakistan and India. Frequent co-authors include Muhammad Ashar Ali, Faiz Anwer, Sana Irfan Khan, Ali Jaan, Kenneth Chen, Hong Hong Huang, Yu Guang Tan, Kae Jack Tay, Moussab Damlaj and Hamid Ehsan. Their work appears in journals such as Blood, British Journal of Oral and Maxillofacial Surgery, The Prostate, Journal of Clinical Oncology and World Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.